Vimarsana
Biggest News Aggregation in the World

Page 36 - Breakthrough Device News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Device Today - Breaking & Trending Today

Shockwave Medical Announces Agreement to Acquire Neovasc - Vimarsana News

Shockwave Medical Announces Agreement to Acquire Neovasc

Neovasc’s Innovative Reducer System will target the estimated $5 billion refractory angina market

MedRhythms Announces Positive Topline Results from Pivotal Trial in Chronic Stroke - Vimarsana News

MedRhythms Announces Positive Topline Results from Pivotal Trial in Chronic Stroke

/PRNewswire/ -- MedRhythms announced today that the company's pivotal trial for MR-001, a novel digital intervention in development to treat gait deficits in...

Two Biotech Firms, Co-Founder to Resolve Federal Grant Audit Allegations - Vimarsana News

Two Biotech Firms, Co-Founder to Resolve Federal Grant Audit Allegations

/PRNewswire/ -- iSense and its co-founder Dr. Paul Andrew Rhodes have settled an investigation arising from a U.S. Defense Contract Audit Agency (DCAA) draft...

IONIQ Sciences, Inc.: IONIQ Sciences to Present at Biotech Showcase - Vimarsana News

IONIQ Sciences, Inc.: IONIQ Sciences to Present at Biotech Showcase

SALT LAKE CITY, UT / ACCESSWIRE / January 5, 2023 / ProLung, Inc. dba IONIQ Sciences, Inc. ("IONIQ" or the "Company") today announced it is presenting in person at Biotech Showcase, the investor conference

US FDA Grants Breakthrough Designation for Blood Test to Help Diagnose Inaccessible Brain Tumors - Vimarsana News

US FDA Grants Breakthrough Designation for Blood Test to Help Diagnose Inaccessible Brain Tumors

Mumbai (Maharashtra) [India], January 3 (ANI/PRNewswire): Datar Cancer Genetics announced today that the US Food and Drug Administration (FDA) has granted 'Breakthrough Device Designation' for its 'TriNetra-Glio', a blood test to help in the diagnosis of brain tumors